Professor Colin Dayan



Prosiectau fel Prif Ymchwiliwr
null null 7 o 7 null null

Clinical trials in the Type 1 Diabetes UK Immunotherapy Consortium: Bigger smarter faster - Cyllidwr:Juvenile Diabetic Research Foundation, - Cyllidwr:Diabetes UK (01.05.2019 - 30.04.2022)
The beta-2 score and beyond: new composite outcomes measures of islet cell function for use in clinical trials - Cyllidwr:Juvenile Diabetic Research Foundation (01.10.2019 - 30.09.2022)
Reducing the impact of diabetic foot ulcers on patients and the health service: The REDUCE programme - Cyllidwr:National Institute for Health Research (01.03.2020 - 31.12.2025)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 3 null null

Microneedle delivery of antigen-specific immunotherapy for type 1 diabetes - Cyllidwr:Engineering and Physical Sciences Research Council (01.10.2014 - 30.09.2018)
B cells in newly diagnosed type 1 diabetes - Cyllidwr:Diabetes UK (01.03.2012 - 31.07.2016)
Peptide-HLA multimers as biomarkers of autoimmune disease - Cyllidwr:Wellcome Trust (01.07.2012 - 31.07.2014)

Diweddarwyd y tro diwethaf ar 2020-28-06 am 04:06